Phase II study of nimustine, carboplatin, vincristine, and interferon-beta with radiotherapy for glioblastoma multiforme: experience of the Kyoto Neuro-Oncology Group.

Aoki, Tomokazu; Takahashi, Jun A; Ueba, Tetsuya; Oya, Natsuo; Hiraoka, Masahiro; Matsui, Kunihiko; Fukui, Tsugiya; Nakashima, Yasuaki; Ishikawa, Masatsune; Hashimoto, Nobuo

Aoki, Tomokazu; Takahashi, Jun A; Ueba, Tetsuya; Oya, Natsuo; Hiraoka, Masahiro; Matsui, Kunihiko; Fukui, Tsugiya; Nakashima, Yasuaki; Ishikawa, Masatsune; Hashimoto, Nobuo.

Affiliation

Aoki T; Department of Neurosurgery, Kitano Hospital Medical Research Institute, Osaka, Japan. tomokazu@kitano-hp.or.jp

J Neurosurg ; 105(3): 385-91, 2006 Sep.

Article in En | MEDLINE | ID: mdl-16961130

Subject(s)

Antineoplastic Combined Chemotherapy Protocols/administration & dosage; Brain Neoplasms/drug therapy; Brain Neoplasms/radiotherapy; Glioblastoma/drug therapy; Glioblastoma/radiotherapy; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols/adverse effects; Carboplatin/administration & dosage; Drug Tolerance; Female; Humans; Interferon-beta/administration & dosage; Male; Middle Aged; Nimustine/administration & dosage; Vincristine/administration & dosage

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Brain Neoplasms / Antineoplastic Combined Chemotherapy Protocols / Glioblastoma Limits: Adult / Aged / Female / Humans / Male / Middle aged Language: En Journal: J Neurosurg Year: 2006 Type: Article Affiliation country: Japan

Search on Google

XML

PubMed Links